COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week;
Final first round of allocations for doses of AstraZeneca/Oxford and Pfizer-BioNTech vaccines, to the majority of countries and economies participating in the COVAX Facility, anticipated to be published in coming days; Beginning of global rollout means that, as readiness criteria are met and doses produced, vaccines will be shipped to Facility participants on a rolling basis.
Today, Ghana became the first country outside India to receive COVID-19 vaccine doses shipped via the COVAX Facility. This is a historic step towards our goal to ensure equitable distribution of COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals that will continue in the coming days and weeks.
Adobe
After months of uncertainty and frustration, a World Health Organization program designed to ensure access to Covid-19 vaccines in dozens of low-income countries late last week received a spate of good news.
First, one vaccine maker, Novavax (NVAX), pledged 1.1 billion doses of its shot to the WHO effort, which is known as COVAX. Meanwhile, the U.S. agreed to contribute $4 billion in aid over the next two years, with Germany adding $1.2 billion and the European Commission providing $600 million. Collectively, the G7 countries have now committed a total $7.5 billion. And the U.K. promised to provide surplus vaccines to low-income countries.
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Law enforcement sources, crime analysts and others have identified free trade zones as arguably the biggest threat to the safety of vaccine supplies in Africa.
Mombasa is at the top of the list of ports already a major conduit for falsified and substandard medicines.
Lack of a continental strategy to stop the spread of fake Covid vaccines means countries are acting in isolation.
Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow streets, some cobbled with sea-stones, calcified by the centuries that have passed since they were laid.
The air, always humid, is aromatic with sweet spices and fish, salt-washed from the nearby sea; the cacophony of the many markets and the muezzins call to prayer add to an atmosphere already heavy on the senses.